ERIS LIFESCIENCES
Back to Balance Sheet
|
ERIS LIFESCIENCES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹64 Cr | ₹54 Cr | ₹28 Cr | ₹25 Cr | ₹20 Cr |
What is the latest Contingent Liabilities ratio of ERIS LIFESCIENCES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹64 Cr |
| Mar2024 | ₹54 Cr |
| Mar2023 | ₹28 Cr |
| Mar2022 | ₹25 Cr |
| Mar2021 | ₹20 Cr |
How is Contingent Liabilities of ERIS LIFESCIENCES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹64 Cr | 19.17 | |
| Mar2024 | ₹54 Cr | 90.05 | |
| Mar2023 | ₹28 Cr | 15.82 | |
| Mar2022 | ₹25 Cr | 25.02 | |
| Mar2021 | ₹20 Cr | - | |
Compare Contingent Liabilities of peers of ERIS LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ERIS LIFESCIENCES | ₹19,118.5 Cr | -3.3% | -7.6% | 13.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹386,773.0 Cr | -3.6% | -6.8% | -5.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,540.0 Cr | -5.4% | -2.4% | 3.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,529.0 Cr | 3.6% | 8.5% | 23.5% | Stock Analytics | |
| CIPLA | ₹111,299.0 Cr | -5.1% | -7.1% | -3.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,393.0 Cr | -4.1% | -8.3% | -12.1% | Stock Analytics | |
ERIS LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ERIS LIFESCIENCES | -3.3% |
-7.6% |
13.5% |
| SENSEX | -2% |
-2.8% |
7.4% |
You may also like the below Video Courses